StockData

Andersen vs HealthEquity

ANDG and HQY side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ANDG and HQY compare

HealthEquity is the larger company, worth 1.2 times as much as Andersen ($8.4B against $7.1B).

HealthEquity scores higher on the StockData Score (15 against 4 for Andersen), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricANDGHQY
Size and price
Market cap$7.1B$8.4B
Share price$63.08$101.84
Change, 1 year–0.07%
Change, 5 years–77.5%
Beta (5Y)–0.39
Employees2,3002,814
StockData Score
Total score415 (better)
Valuation score03 (better)
Growth score13 (better)
Performance score04 (better)
Health score35 (better)
Dividend score00
Valuation
P/E–36.8×
P/S7.4×6.2× (better)
P/B–4.2×
EV/EBITDA–17.9×
P/FCF34.6×17.3× (better)
FCF yield2.9%5.8% (better)
Fair value$13.52$110.02
Margin of safety−367%7.4% (better)
Growth
Revenue growth (TTM)–7.3%
Revenue growth, 5Y average–12.4%
Net income growth (TTM)–62.2%
EPS growth (TTM)–67.9%
EPS growth, 5Y average–83.0%
Profitability
Gross margin32.6%71.2% (better)
Operating margin−8.5%25.8% (better)
Net margin–17.4%
FCF margin21.3%35.8% (better)
Return on equity–11.4%
Return on invested capital–9.8%
Financial health
Debt / equity–0.47
Net debt / EBITDA–1.33
Interest coverage−4.3×6.7× (better)
Current ratio2.522.99 (better)
Altman Z-score6.83 (better)4.90
Piotroski F-score–9
Dividends and buybacks
Buyback yield–4.8%
Shareholder yield0.00%4.8% (better)
Ownership
Held by institutions14.7%109%
Held by insiders0.04%1.4%
Insider net buying, 12 months−$5.3M−$4.1M (better)
Superinvestors holding1–
Short interest, % of float2.3%6.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.